HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tirone E. David George T. Christakis Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by David, T. E. Articles by Christakis, G. T. Search for Related Content PubMed PubMed Citation Articles by David, T. E. Articles by Christakis, G. T.

Ann Thorac Surg 1985;40:229-233
© 1985 The Society of Thoracic Surgeons

---

Articles

Thromboembolism in Patients with Aortic Porcine Bioprostheses

From the Division of Cardiovascular Surgery, Toronto Western Hospital, University of Toronto, Toronto, Ont, Canada

^* Address reprint requests to Dr. David, 399 Bathurst St, Toronto, Ont, Canada M5T 2S8

Thromboembolism was prospectively studied in 215 patients who survived aortic valve replacement with porcine bioprostheses. All patients were anticoagulated with warfarin sodium during the first 3 postoperative months. Thereafter, 80 patients received aspirin (325 or 650 mg per day) and 135 received no antiplatelet or anticoagulant drugs. The two groups of patients were similar. Thromboembolic complications were carefully searched for during the follow-up interviews. Patients were removed from the study after a thromboembolic event unless there was no change in their management.

The follow-up ranged from 6 to 80 months (mean, 36 months). The linearized thromboembolic rate in patients on a regimen of aspirin was 1.3% per patient-year and in patients not taking aspirin, 5.2% per patient-year (p < 0.02). Replacement of the ascending aorta and patch enlargement of the aortic annulus with a Teflon graft were identified as significant risk factors for thromboembolism in patients with aortic porcine bioprostheses.

These findings indicate that patients with aortic porcine bioprostheses should receive aspirin, especially if they also had replacement of the ascending aorta or patch enlargement of the aortic annulus with a Teflon graft.

This article has been cited by other articles:

				N. D. Desai and G. T. Christakis Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894. [Full Text]

				T. Gherli, A. Colli, C. Fragnito, F. Nicolini, B. Borrello, S. Saccani, R. D'Amico, and C. Beghi Comparing Warfarin With Aspirin After Biological Aortic Valve Replacement: A Prospective Study Circulation, August 3, 2004; 110(5): 496 - 500. [Abstract] [Full Text] [PDF]

				N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text]

				T. E. David, S. Armstrong, and Z. Sun The Hancock II bioprosthesis at ten years Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S229 - S234. [Abstract] [PDF]

				T. E. David, S. Armstrong, and Z. Sun Clinical and hemodynamic assesment of the Hancock II bioprosthesis Ann. Thorac. Surg., October 1, 1992; 54(4): 661 - 668. [Abstract] [PDF]

				A. D. Milano, U. Bortolotti, A. Mazzucco, F. Guerra, G. Stellin, E. Talenti, G. Thiene, and V. Gallucci Performance of the Hancock Porcine Bioprosthesis Following Aortic Valve Replacement: Considerations Based on a 15-Year Experience Ann. Thorac. Surg., August 1, 1988; 46(2): 216 - 222. [Abstract] [PDF]

				L. H. Edmunds Jr. Thrombotic and Bleeding Complications of Prosthetic Heart Valves Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445. [Abstract] [PDF]

				A. Damle, J. Coles, J. Teijeira, C. Pelletier, and J. Callaghan A Six-Year Study of the Omniscience Valve in Four Canadian Centers Ann. Thorac. Surg., May 1, 1987; 43(5): 513 - 521. [Abstract] [PDF]